Novo Nordisk Canada will now offer its Ozempic Savings Card to Canadians with private drug plans, letting eligible members buy the brand-name semaglutide at a price the company says is aligned with generic alternatives.
The change took effect immediately, according to Novo Nordisk Canada.
The expansion applies across the country except Quebec, and builds on discounts the company already offered to patients paying entirely out-of-pocket.
Novo Nordisk said all patients with private coverage will see savings through the card regardless of their copay amount when they choose Ozempic.